Company Profile

TheraFuse has proven the fundamental principle of thermal time-of-flight can be used to measure fluid flow rate over the range of drug infusion rates required for most therapeutic settings, from the very low infusion rates for basal insulin in neonates to the very high infusion rates required for IV drug delivery in a hospital setting. TheraFuse has designed completely stand-alone prototypes to further demonstrate the robustness of the technology in non-laboratory settings. The performance of these prototypes has been measured in AAMI-compliant accuracy and precision studies and in animal studies. R&D drug delivery and glucose monitoring systems. Flow sensor application to low flow rate measurements.